Home  >  TopNews
TopNews
  Karnataka drugs control dept to modernise infrastructure, streamline processes,   October 18, 2017
  Maha FDA scrutinizes self audit reports from manufacturers before inspections for compliance,   October 17, 2017
  DoP's move to cap trade margin not enough to curb drug prices: AICDF,   October 17, 2017
  Union govt to launch dedicated medical & wellness tourism policy next year,   October 16, 2017
  DCGI issues registration certificate of Lactitol to Shandong Lujian,   October 16, 2017
  Chennai CDSCO enters into second phase of e-governance, industry and regulators hail high-tech operations,   October 12, 2017
  Centre plans to frame exclusive policy on bulk drugs, medical devices, formulation parks to address costly imports,   October 12, 2017
  Centre to part finance new drug testing lab costing Rs. 45 cr at Vadodara in Gujarat,   October 11, 2017
  India specific study for intensive ADR monitoring on pioglitazone to start soon,   October 09, 2017
  DCGI directs drug testing labs across country to do self audit before CDSCO inspections,   October 09, 2017
  Exclusive category of OTC drugs soon, state drug controllers to be consulted,   October 06, 2017
  Bihar drug units forced to keep Rs.60 lakh worth levofloxacin & ofloxacin composition in godowns due to DC's ban order,   October 06, 2017
  Health ministry launches mobile app for patients, healthcare professionals to report ADR,   October 05, 2017
  Goa FDA calls for regulation & technology upgradation of supply chain to curb counterfeiting,   October 05, 2017
  Health ministry releases pharmacovigilance guidelines to ensure ease of doing PV practices,   October 04, 2017
  Health ministry issues draft rules to facilitate sales of drugs online,   October 04, 2017
  Gujarat govt to set up rapid microbiological testing lab in the state to detect contaminants in medicines,   October 03, 2017
  DoP asks NPPA to take Expert Committee's opinion for fixing ceiling price of methylprednisolone Inj 40 mg/ml,   October 03, 2017
  DoP invokes Para 3 of DPCO-2013 to ensure compliance of price capping of coronary stents and its uninterrupted supply,   September 29, 2017
  DoP invokes Para 3 of DPCO, 2013 to ensure uninterrupted supply of knee implant system,   September 28, 2017

 Back
 
IPJPI_150x60en_2017
acssymposium
CPhI-WWW-150x60-stat-v1
PHARMACONNECT_2018
 
 
 
 
Copyright © 2016 Saffron Media Pvt. Ltd |